Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 5,023 | 5,092 | 14,344 | 12,702 | 3,439 |
| Cost of Goods | 889 | 1,401 | 1,109 | 494 | 437 |
| Gross Profit | 4,134 | 3,691 | 13,235 | 12,208 | 3,002 |
| Operating Expenses | 14,738 | 11,284 | 11,717 | 11,192 | 11,569 |
| Operating Income | -9,715 | -7,192 | 1,627 | 1,510 | -8,130 |
| Interest Expense | 160 | 1,314 | 2,094 | 2,131 | 2,203 |
| Other Income | 193 | 432 | 193 | 825 | 591 |
| Pre-tax Income | -9,682 | -8,074 | -274 | 204 | -9,742 |
| Net Income Continuous | -9,682 | -8,074 | -274 | 204 | -9,742 |
| Net Income | $-9,682 | $-8,074 | $-274 | $204 | $-9,742 |
| EPS Basic Total Ops | -0.45 | -0.64 | -0.03 | 0.02 | -1.03 |
| EPS Basic Continuous Ops | -0.45 | -0.64 | -0.03 | 0.02 | -1.03 |
| EPS Diluted Total Ops | -0.45 | -0.64 | -0.03 | 0.02 | -1.03 |
| EPS Diluted Continuous Ops | -0.45 | -0.64 | -0.03 | 0.02 | -1.03 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.56 | 0.05 | 0.02 | -1.00 |
| EBITDA(a) | $-9,521 | $-7,002 | $1,811 | $1,709 | $-7,922 |